Takeda recalls Natpara from the US due to faulty pens
Takeda recalls all lots of Natpara from the US market due to danger of rubber fragments detaching into the cartridge of the pen during administration.
Archives for September 10, 2019
Lonza works with Celltrion to ensure supply of Remsima drug substance
Lonza’s facility in Singapore will provide Celltrion with the drug substance product to meet demand for the latter’s Remsima biosimilar in the European and US market.
Noile-Immune’s tech gets $315m vote of confidence to tackle solid tumors
Noile-Immune signs its second high profile agreement, the latest with Adaptimmune to combine the companies’ technology in pre-clinical studies for the treatment of cancer.